Determinants of Pterygium Occurrence and Recurrence in a Rural African Population
NCT ID: NCT00713180
Last Updated: 2015-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
355 participants
INTERVENTIONAL
2008-08-31
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study hypothesis is that multiple factors are responsible for the occurrence and recurrence of pterygium in a rural african population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Corneal Topographic Changes After Pterygium Surgery
NCT05026307
Clinical Analysis of Recurrence Patterns Following Conjunctival Autografts for Pterygium Surgery
NCT02059837
Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery
NCT03321201
A Novel Technique for the Removal of Pterygiums
NCT02321150
Comparison Between Sutureless and Glue Free Versus Sutured Limbal Conjunctival Autograft in Primary Pterygium Surgery
NCT02009072
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Pterygium free participants
No interventions assigned to this group
2
Pterygium participants
Pterygium excision followed by grafting
Pterygium will be excised followed by either free conjunctival or limbal conjunctival graft obtained from the upper part of the globe. The graft will be kept in place by sutures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pterygium excision followed by grafting
Pterygium will be excised followed by either free conjunctival or limbal conjunctival graft obtained from the upper part of the globe. The graft will be kept in place by sutures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Both male and female
3. Age range 21-65 years
4. Consenting to participate in study
5. Unilateral and bilateral pterygium
6. All grades of pterygium
Exclusion Criteria
2. Pseudopterygium or signs of malignancy on pterygium
3. Recurrent pterygium
4. Sufferers of collagen vascular disease, scleritis or diabetes -
21 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anguria, Peter, M.D.
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mankweng Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Anguria, MMed
Role: PRINCIPAL_INVESTIGATOR
Mankweng Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mankweng Hospital
Polokwane, Limpopo, South Africa
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Research laboratory
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.